Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
PE-22-28 (Mini-Spadin) blocks TREK-1 potassium channels with ~100-fold greater potency than its parent compound, demonstrating BDNF upregulation, rapid neurogenesis within 4 days, and cognitive benefits in stroke models (Djillani et al., 2017 in Frontiers in Pharmacology)
Key Takeaways Wellness clinics catch health problems years before symptoms appear through advanced diagnostics like metabolic analysis and DNA testing, preventing serious conditions from developing
In appropriate doses given by a trained injector it has a strong safety record, with only minor effects like injection-site tenderness
This function has led to the hypothesis that L-Carnitine could help increase fat burning and, consequently, promote weight loss
When levels drop, or your detox pathways get backed up, it can help to supplement with glutathione
Clinical Indications and Who May Benefit Based on the preclinical literature and emerging clinical use patterns, BPC-157 is most commonly applied in the following areas: Tendon, ligament, and muscle injuries (sprains, partial tears, chronic tendinopathy) Post-surgical tissue healing and recovery acceleration Inflammatory bowel conditions (Crohns, ulcerative colitis, leaky gut syndromes) NSAID-induced gastric damage notably, BPC-157 counteracts aspirin- and ibuprofen-driven mucosal injury Neuropathy and nerve regeneration protocols Systemic inflammation and autoimmune flares Recovery from alcohol-related liver and gut damage It is also increasingly used as a component in broader peptide therapy protocols alongside BPC-157s companion compounds
US$ 27.27
US$ 26.58
US$ 29.35
US$ 23.05
